By Katherine Hamilton

LifeMD shares slid after the company lowered its full-year sales guidance following its divestiture from WorkSimpli.

The stock slipped 22% to $3.67 in after-hours trading Monday. Through the close shares were down 4.5% this year.

In the current fourth quarter, the telehealth company forecasts revenue of $45 million to $46 million, missing the $65.2 million analysts polled by FactSet were expecting.

The company's full-year outlook for sales of $192 million to $193 million was below the $252.6 million analysts anticipated. LifeMD had previously been forecasting full-year revenue of $250 million to $255 million.

Earlier this month, LifeMD said it was divesting its interest in the document-management platform WorkSimpli. The new guidance reflects the divestiture, including a $1.1 million adjustment for the year, the company said.

LifeMD also said the weight-management market has remained challenged due to fierce competition from low-price compounded GLP-1 providers.

For the third quarter, the company said revenue increased 13% to $60.2 million, which was below the $62.1 million forecast by Wall Street.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

November 17, 2025 18:45 ET (23:45 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.